Variants of bcl-2 specific siRNA For silencing antiapoptotic bcl-2 in pancreatic cancer

Ocker, M.; Neureiter, D.; Lueclers, M.; Zopf, S.; Ganslmayer, M.; Hahn, E. G.; Herold, C.; Schuppan, D.
September 2005
Gut;Sep2005, Vol. 54 Issue 9, p1298
Academic Journal
Background and aims: Pancreatic cancer remains a devastating diagnosis with only limited therapeutic options. Specific inhibition of expression of target genes has become possible using small interfering (si) RNAs. We therefore investigated how far siRNA specific for bcl-2 may serve as a therapeutic option for pancreatic cancer in vitro and in vivo. Methods: siRNAs targeting two different regions in the bcl-2 gene were transfected to YAP C and DAN G pancreatic carcinoma cells and human foreskin fibroblasts. Permutations were generated by changing 3' and 5' overhangs and varying the length of the paired RNA duplex. Transfection efficacy was determined using FITC labelled siRNAs and fluorescence microscopy. Cell survival and apoptosis were quantified at 24-120 hours. Pancreatic cancer xenografts in male nude mice were treated intraperitoneally with siRNAs daily for 24 days. siRNA pharmacokinetics in vivo were assessed using radioactively labelled siRNAs. Total protein and RNA were extracted for western Blot analysis and quantitative polymerase chain reactions Results and conclusions: bcl-2 specific siRNAs specifically inhibited expression of the target gene in vitro and in vivo. Antiproliferative and proapoptotic effects were observed in tumour cells but not in fibroblasts or non-malignant tissues. siRNA permutations and diverse overhangs influenced gene silencing efficacy. siRNA was quickly distributed to all organs and excreted via the kidney and liver. bcl-2 specific siRNA is a promising adlunctive treatment for pancreatic carcinoma.


Related Articles

  • Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Shindo, Koji; Aishima, Shinichi; Ohuchida, Kenoki; Fujiwara, Kenji; Fujino, Minoru; Mizuuchi, Yusuke; Hattori, Masami; Mizumoto, Kazuhiro; Tanaka, Masao; Oda, Yoshinao // Molecular Cancer;2013, Vol. 12 Issue 1, p1 

    Background Interactions between cancer cells and surrounding cancer-associated fibroblasts (CAFs) play an important role in cancer progression. Invasive ductal carcinoma (IDC) of the pancreas is characterized by abundant fibrous connective tissue called desmoplasia. Podoplanin (PDPN) is a...

  • Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Gerhard, M.C.; Schmid, R.M.; Hacker, G. // British Journal of Cancer;3/18/2002, Vol. 86 Issue 6, p893 

    Examines the integrity of the cytochrome c-dependent apoptotic apparatus in human pancreatic carcinoma cell lines. Expression of Apaf-I and caspases; Correlation between the amount of processing of caspase-9 and effector caspases.

  • Therapeutics: Akt: a double-edged sword. Swami, Meera // Nature Reviews Cancer;Feb2009, Vol. 9 Issue 2, p76 

    The article reports on Akt, a serine/threonine kinase which frequently occurs in human cancers. It states that a study has highlighted an Achilles heel of Akt which shows that tumor cells activate Akt in order to proliferate and escape apoptosis. The research showed that cellular lifespan in...

  • Induction of Apoptosis in Tumor-Associated Endothelial Cells and Therapy of Orthotopic Human Pancreatic Carcinoma in Nude Mice. Yokoi, Kenji; Sun-Jin Kim; Thaker, Premal; Yazici, Sertac; Do-Hyun Nam; Junqin He; Sasaki, Takamitsu; Chiao, Paul J.; Sclabas, Guido M.; Abbruzzese, James L.; Hamilton, Stanley R.; Fidler, Isaiah J. // Neoplasia;Jul2005, Vol. 7 Issue 7, p696 

    Although gemcitabine has been accepted as the first-line chemotherapeutic reagent for advanced pancreatic cancer, improvement of response rate and survival is not sufficient and patients often develop resistance. We hypothesized that the inhibition of phosphorylation of epidermal growth factor...

  • Gene expression profiles of pancreatic cancer and stromal desmoplasia. Crnogorac-Jurcevic, Tatjana; Efthimiou, Evangelis; Capelli, Paola; Blaveri, Ekaterina; Baron, Antonella; Terris, Benoit; Jones, Melanie; Tyson, Kerry; Bassi, Claudio; Scarpa, Aldo; Lemoine, Nicholas R // Oncogene;11/1/2001, Vol. 20 Issue 50, p7437 

    Gene expression studies were undertaken in normal pancreas and pancreatic adenocarcinomas to determine new candidate genes that can potentially be used as markers of the disease. The characteristic desmoplastic stromal reaction of pancreatic adenocarcinoma greatly hampers expression studies in...

  • On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis. Ryu, S. J.; An, H. J.; Oh, Y. S.; Choi, H. R.; Ha, M. K.; Park, S. C. // Cell Death & Differentiation;Nov2008, Vol. 15 Issue 11, p1673 

    Major vault protein (MVP), the main component of vault complex, is overexpressed in many multidrug-resistant cancer cell lines, suggesting a possible role for MVP in cell signaling and survival. In this study, we have found that MVP is markedly increased in senescent human diploid fibroblasts...

  • Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Goicoechea, S M; García-Mata, R; Staub, J; Valdivia, A; Sharek, L; McCulloch, C G; Hwang, R F; Urrutia, R; Yeh, J J; Kim, H J; Otey, C A // Oncogene;3/6/2014, Vol. 33 Issue 10, p1265 

    The stromal compartment surrounding epithelial-derived pancreatic tumors is thought to have a key role in the aggressive phenotype of this malignancy. Emerging evidence suggests that cancer-associated fibroblasts (CAFs), the most abundant cells in the stroma of pancreatic tumors, contribute to...

  • Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Whitehurst, Angelique W.; Bodemann, Brian O.; Cardenas, Jessica; Ferguson, Deborah; Girard, Luc; Peyton, Michael; Minna, John D.; Michnoff, Carolyn; Weihua Hao; Roth, Michael G.; Xian-Jin Xie; White, Michael A. // Nature;4/12/2007, Vol. 446 Issue 7137, p815 

    Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery driving proliferation and suppressing apoptosis. Anomalous proteins engaged in support of this tumorigenic regulatory environment most...

  • Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Yinhong Song; Changju Zhang // Cancer Chemotherapy & Pharmacology;Mar2009, Vol. 63 Issue 4, p605 

    The tumor suppressor adenomatous polyposis coli (APC) is frequently silenced by promoter hypermethylation in human cervical cancer. Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2′-deoxycytidine (5-Aza-dC), can reverse APC promoter methylation, but...


Read the Article


Sign out of this library

Other Topics